PROPHASE LABS INC(PRPH)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $0.07 – $6.66
- YTD
- -25.51%
- IV Rank (30D)
- 77.98
- Straddle Price
- $1.55
- Market Cap
- $0.0B
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834)
- Exchange
- OTC Link
- Market Cap
- $0.0B
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in …
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -3.80% | 16 |
| Feb | +0.08% | 16 |
| Mar | +1.13% | 16 |
| Apr | -2.83% | 16 |
| May | +2.07% | 17 |
| Jun | -3.18% | 17 |
| Jul | +4.04% | 16 |
| Aug | -2.93% | 16 |
| Sep | +5.72% | 16 |
| Oct | +6.82% | 16 |
| Nov | +3.00% | 16 |
| Dec | -10.26% | 16 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-14 | After-Close | 18.00% | 9.60% | 0.53x | Within |
| 2024-11-13 | Pre-Market | 328.21% | 1.34% | 0.00x | Within |
| 2025-03-31 | After-Close | 131.25% | 7.75% | 0.06x | Within |
| 2025-05-20 | Pre-Market | 116.97% | 0.09% | 0.00x | Within |
| 2025-08-13 | After-Close | 152.72% | 1.56% | 0.01x | Within |
| 2025-11-19 | After-Close | 1081.37% | 17.99% | 0.02x | Within |
- IV Rank (30D)
- 77.98
- IV Rank (7D)
- 0
- Avg IV
- 1156.8%
- Straddle (30D)
- $1.55
- Straddle (7D)
- $1.17
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.90
- Correlation (SPY)
- 14.4%
- R²
- 0.02
- Ann. Volatility
- 161.2%
- SPY Volatility
- 12.2%
High volatility - stock moves more than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2025-09-11 | Ted William Karkus | CEO & CHAIRMAN | Grant (A) | +500,000 RSU | — | EDGAR | |
| 2025-02-21 | Stuart Hollenshead | Chief Operating Officer | Grant (A) | +500,000 opt | — | EDGAR | |
| 2025-02-18 | LOUIS MD GLECKEL | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2025-02-18 | Warren Hirsch | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2024-03-21 | Ted William Karkus | CEO & CHAIRMAN | Grant (A) | +400,000 opt | — | EDGAR | |
| 2024-03-19 | Warren Hirsch | Director | Grant (A) | +70,000 opt | — | EDGAR | |
| 2024-03-19 | Jed Latkin | Director | Grant (A) | +500,000 opt | — | EDGAR | |
| 2024-03-19 | Ted William Karkus | CEO & CHAIRMAN | Grant (A) | −400,000 opt | — | EDGAR | |
| 2024-03-19 | Jason Michael Barr | Director | Grant (A) | +70,000 opt | — | EDGAR | |
| 2024-03-19 | LOUIS MD GLECKEL | Director | Grant (A) | +70,000 opt | — | EDGAR | |
| 2023-06-22 | Jason Michael Barr | Director | Grant (A) | +40,000 opt | — | EDGAR | |
| 2023-06-22 | Warren Hirsch | Director | Grant (A) | +40,000 opt | — | EDGAR | |
| 2023-06-22 | LOUIS MD GLECKEL | Director | Grant (A) | +40,000 opt | — | EDGAR | |
| 2023-06-21 | Jason Michael Barr | Director | Grant (A) | +40,000 opt | — | EDGAR | |
| 2023-06-21 | LOUIS MD GLECKEL | Director | Grant (A) | +40,000 opt | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ted William Karkus | CEO & CHAIRMAN | 3,583,750 | $394.2K | -$1.00M | 31 | 2025-09-11 |
| 2 | GUY J QUIGLEY | 10%+ Owner | 2,986,264 | $328.5K | -$11.0K | 3 | 2012-09-06 |
| 3 | Mark S Leventhal | Director | 1,030,480 | $113.4K | $316.0K | 17 | 2015-12-08 |
| 4 | Braden Michael Leonard | 10%+ Owner | 627,322 | $69.0K | -$3.16M | 7 | 2017-10-02 |
| 5 | Mark A. Burnett | Director | 318,282 | $35.0K | $86.6K | 12 | 2018-10-02 |
| 6 | John DeShazo | Director | 283,515 | $31.2K | $0 | 1 | 2010-07-13 |
| 7 | LOUIS MD GLECKEL | Director | 273,840 | $30.1K | $312.5K | 26 | 2025-02-18 |
| 8 | ROBERT V JR CUDDIHY | Chief Financial Officer | 132,703 | $14.6K | -$824.8K | 12 | 2017-10-02 |
| 9 | Mark Shawn Frank | Director | 79,235 | $8.7K | $33.0K | 9 | 2015-01-05 |
| 10 | Monica L. Brady | Chief Accounting Officer | 34,872 | $3.8K | $0 | 4 | 2022-05-25 |
| 11 | JAMES T MCCUBBIN | Director | 31,829 | $3.5K | $1.3K | 9 | 2015-01-05 |
| 12 | Jason Michael Barr | Director | 30,962 | $3.4K | $22.5K | 14 | 2024-03-19 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.